Biokanol Pharma GmbH is a medium-sized pharmaceutical company headquartered in Rastatt with a branch in Oetigheim (since early 2021). The company provides full-service pharmaceutical services including packaging, repacking, serialization, tamper-evident sealing, shrink-wrapping, distribution, sales including debt collection and specialized processing for custom requests. A modern pharmaceutical warehouse in Oetigheim with 5,000 m² of floor space and nearly 8,000 pallet locations is used for storage and shipping, and about 20 million packages are delivered annually. Recipients include pharmaceutical wholesalers, pharmacies, veterinarians and end consumers; the company holds GMP certification, manufacturing and importer licenses under §72a AMG and a wholesale license (§52a AMG).
Die Herstellung, Verpackung und der Vertrieb von Arzneimitteln, Tierarzneimitteln und anderen Produkten sowie Dienstleistungen für Partner im Gesundheitswesen. Die Gesellschaft darf auch andere verwandte Geschäfte betreiben. Sie kann andere Unternehmen erwerben, pachten, vertreten oder sich an solchen Unternehmen beteiligen. Sie darf Zweigniederlassungen im In- und Ausland errichten. Die Gesellschaft darf alle Geschäfte vornehmen, die der Erreichung und Förderung des Gesellschaftszweckes dienlich sein können.
Converted using the official Destatis and Eurostat correspondence tables; ISIC Rev. 4 is the United Nations' international industry classification.
This summary was generated with the help of AI. See our Data Quality Notice. Report error?
Source: German Commercial Register (Handelsregister) Mannheim Local Court, HRB 521796 (as of 30 October 2026)
| Name | Type | City |
|---|---|---|
| Sylvia Weimer-Hartmann | Geschäftsführer(in) | Rastatt |
Source: German Commercial Register (Handelsregister) Mannheim Local Court, HRB 521796 (as of 30 October 2026)
| Year | Revenue | Profit | Balance | Employees |
|---|---|---|---|---|
| 2024 | Rohergebnis€6.6M2 | -€416,618 | €8,101,827 | — |
| 2023 | Rohergebnis€6.6M2 | -€208,627 | €8,031,890 | — |
| 2022 | Rohergebnis€5.9M2 | -€25,801 | €7,096,372 | — |
| 2021 | Rohergebnis€4.2M2 | -€174,898 | €6,172,519 | — |
| 2020 | small company1 | — | €2,898,848 | — |
| 2019 | small company1 | — | €2,587,164 | — |
| 2018 | small company1 | — | €2,658,356 | — |
| 2017 | small company1 | — | €2,270,271 | — |
| 2016 | small company1 | — | €2,206,025 | — |
| 2015 | small company1 | -€3,917 | €2,507,607 | — |
1 Small companies are not required to publish a profit-and-loss statement (§ 326 (1) HGB). The figure shown is the statutory ceiling under § 267 HGB where the balance-sheet total makes it binding — a company may exceed at most one of the three size criteria.
2 Rohergebnis nach § 276 HGB: Umsatzerlöse abzüglich Materialaufwand bzw. Herstellungskosten. Kleine und mittelgroße Kapitalgesellschaften dürfen diese Posten zusammenfassen; die Umsatzerlöse selbst sind dann nicht veröffentlicht und liegen über dem Rohergebnis.
Sign in to download data
Source: German Commercial Register (Handelsregister) Mannheim Local Court, HRB 521796 (as of 30 October 2026)
| Cost type | Amount | Share |
|---|---|---|
| Personnel Costs | €3,087,730 | 92.5% |
| Depreciation | €241,817 | 7.2% |
| Interest & Similar | €7,336 | 0.2% |
